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The epidermis has a requirement for fatty acids in order
to synthesize cellular membranes and the extracellular
lipid lamellar membranes in the stratum corneum. Des-
pite high endogenous production of fatty acids the trans-
port of exogenous essential fatty acids into the epidermis
is an absolute requirement. Fatty acid uptake by keratino-
cytes has been shown to be mediated by a transport
system. In this study we determined in murine epidermis
and human cultured keratinocytes the expression of three
putative fatty acid transport related proteins and fatty
acyl CoA synthase, an enzyme that facilitates the uptake
of fatty acids by promoting their metabolism. In cultured
human keratinocytes, mRNA for fatty acid transport
protein (FATP), plasma membrane fatty acid binding
protein (FABP-pm), and fatty acyl CoA synthase (FACS)
were detectable. Differentiation, induced by high cal-
cium, did not affect FATP mRNA levels, but resulted in
The epidermis has a requirement for fatty acids in orderto synthesize cellular membranes and the extracellularlipid enriched lamellar membranes in the stratumcorneum that are responsible for the barrier to watertransit (Schurer and Elias, 1991). Previous studies by our
laboratory and others have shown that the epidermis is a very active
site of de novo fatty acid synthesis (Feingold, 1991). Moreover, disruption
of the permeability barrier results in a 2–3-fold increase in de novo fatty
acid synthesis in the epidermis (Feingold, 1991; Proksch et al, 1993).
Furthermore, inhibition of this increase in fatty acid synthesis delays
barrier repair.
Despite the high endogenous production of fatty acids in the
epidermis, the transport of exogenous fatty acids into the epidermis is
an absolute requirement as the epidermis requires essential fatty acids
and arachidonic acid (Schurer and Elias, 1991). Essential fatty acid
deficiency is characterized by epidermal hyperplasia, scaly skin, and
increased transepidermal water loss (TEWL) (Prottey, 1976; Elias and
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an µ50% increase in FACS mRNA, while decreasing
FABP-pm mRNA by 50%. Fatty acid translocase (FAT)
mRNA was not detected in cultured human keratino-
cytes. In murine epidermis, FATP, FABP-pm, FACS, and
FAT mRNA were all present. Barrier disruption by either
tape stripping or acetone treatment increased FAT mRNA
levels by µ2-fold without affecting FATP, FABP-pm,
or FACS. Occlusion with an impermeable membrane
immediately after barrier disruption completely blocked
the increase in FAT mRNA levels, indicating that this
increase is related to barrier disruption rather than a
nonspecific injury effect. In summary, this study demon-
strates that several putative fatty acid transport related
proteins as well as fatty acyl CoA synthase are expressed
in keratinocytes and epidermis, and that the expression
of these proteins may be regulated by differentiation and/
or barrier disruption. Key words: CD36/FABP-pm/FAT/
FATP/fatty acid uptake. J Invest Dermatol 111:722–726, 1998
Brown, 1978). In the stratum corneum linoleic acid is present in
ω-esterified ceramides 1 and 4, which are localized to the lamellar
bilayers in the stratum corneum and are required for normal barrier
function (Schurer and Elias, 1991; Downing, 1992). In essential fatty
acid deficiency, oleic acid substitutes for linoleate in acyl ceramides,
resulting in the disruption of normal membrane structures and an
incompetent barrier (Wertz et al, 1983). In addition to linoleic acid,
the epidermis also requires exogenous arachidonic acid (C20:4, n-6),
as the enzyme ∆6 desaturase required for arachidonic acid synthesis is
not present in the epidermis (Chapkin and Ziboh, 1984). Arachidonic
acid is the required substrate for eicosanoid synthesis (Sprecher, 1981).
Essential fatty acids are not synthesized by mammalian cells and
therefore must be acquired from dietary sources. Fatty acid uptake by
keratinocytes has been demonstrated to be mediated by a transport
system that is temperature sensitive, has saturable kinetics, and can be
reduced by prior treatment with trypsin, which indicates that plasma
membrane proteins mediate fatty acid uptake (Schurer et al, 1994).
Moreover, keratinocyte fatty acid uptake demonstrated a higher speci-
ficity for the essential fatty acids, i.e., linoleic acid and arachidonic
acid, than for nonessential fatty acids, such as oleic acid (C18:1). These
transport characteristics are not shared with other cell types, such as
hepatocytes, HepG2 cells, and dermal fibroblasts (Schurer et al, 1994),
which transport nonessential and essential fatty acids with similar
kinetics. The identity of the proteins responsible for fatty acid uptake
in keratinocytes has not been established.
Recently, there have been a number of advances in our understanding
of fatty acid transport into cells. In other cell types, three distinct
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proteins have been shown to mediate the uptake of long chain fatty
acids across plasma membranes (Schaffer and Lodish, 1995). Plasma
membrane fatty acid binding protein (FABP-pm) is a 43 kDa protein
that is identical to mitochondrial aspartate aminotransferase (Isola et al,
1995). This protein is expressed in tissues with high fatty acid uptake,
such as the liver and adipose tissue, and levels of FABP-pm expression
correlate with fatty acid transport (Stremmel et al, 1985; Zhou et al,
1995; Berk et al, 1997). Moreover, antibodies to FABP-pm inhibit
fatty acid transport into cells (Stremmel et al, 1985, 1986). Fatty acid
translocase (FAT) is an 88 kDa glycoprotein that has high homology
to human CD36 (Abumrad et al, 1993). FAT is associated with the
plasma membrane and is present in tissues with high fatty acid transport,
such as the muscle, heart, intestine, and adipose tissue (Abumrad et al,
1993; Van Nieuwenhoven et al, 1995). The level of FAT expression
in these tissues correlates with fatty acid transport. Moreover, over-
expression of FAT in cells increases fatty acid uptake (Ibrahimi et al,
1996). Lastly, fatty acid transport protein (FATP) is a 63 kDa protein
that has been shown to be present in 3T3-L-1 adipocytes, adipose
tissue, heart, and muscle, with low levels in kidney, liver, brain, and
lung (Schaffer and Lodish, 1994). FATP is localized to the plasma
membrane and overexpression of this protein increases the uptake of
long chain fatty acids (Schaffer and Lodish, 1994). FATP expression
increases with differentiation in 3T3-L-1 adipocytes and is negatively
regulated by insulin (Schaffer and Lodish, 1994; Man et al, 1996).
Whether any of these three distinct, putative fatty acid transport
proteins are expressed in keratinocytes is not known.
In addition to these transport proteins, the enzyme fatty acyl CoA
synthase (FACS) is also thought to play an important role in cellular
fatty acid uptake (Schaffer and Lodish, 1995). This enzyme catalyzes
the activation of long chain fatty acids to acyl-CoA esters, which are
required for both the oxidation of fatty acids and the esterification of
fatty acids to glycerol to form triglycerides or phospholipids (Kornberg
and Pricer, 1953). The formation of acyl-CoA by preventing the
efflux of fatty acids, assures that transport is a unidirectional process.
Furthermore, expression cloning studies in adipose cells have shown
that FACS is a protein that increases fatty acid uptake into cells (Schaffer
and Lodish, 1994).
The purpose of this study was to determine (i) which of these
proteins FABP-pm, FAT, FATP, and FACS are expressed in murine
epidermis and in human keratinocytes grown in culture; (ii) if differenti-
ation changes the expression of these proteins in cultured keratinocytes;
and (iii) if the expression of these proteins is altered by disruption of
the permeability barrier, a condition that we have previously shown
markedly upregulates de novo fatty acid synthesis in epidermis.
MATERIALS AND METHODS
Materials Hairless male mice (Crl:SKHI-hrBR) were purchased from Charles
River Laboratories (Wilmington, MA). Molecular biology grade chemicals were
purchased from Sigma (St. Louis, MO) and Fischer Scientific (Fairlawn, NJ).
[a-32P] dCTP (3000 Ci per mmol, 10 mCi per ml) was purchased from NEN
Research Products (Boston, MA). The Multiprime Labeling System was
purchased from Amersham International (Amersham, U.K.). Mini-spin columns
(G-50) were purchased from Worthington Biochemical (Freehold, NJ). Oligo-
(dT)-cellulose, type 77F, was purchased from Pharmacia LKB Biotechnology
AB (Uppsala, Sweden). Nytran Plus membrane was purchased from Schleicher
and Schuell (Keene, NH). Spin-X centrifuge filters were purchased from
Corning Costar (Cambridge, MA). cDNA for rat FATP was kindly provided
by J.E. Schaffer (Washington University, St Louis, MO). cDNA for rat FABP-
pm was kindly provided by J.R. Mattingly (University of Missouri, Kansas
City, MO). cDNA for rat FAT was kindly provided by N. Abumrad (SUNY,
Stony Brook, NY). cDNA for rat cyclophilin cDNA (pCD15:8–1) was kindly
provided by Dr. G. Strewler, (Harvard Medical School, MA). cDNA for FACS
was kindly provided by Dr. P. Smith (Abbott Labs, Columbus, OH). Fuji RX
film was used for autoradiography.
Keratinocyte culture Human foreskin keratinocytes, second passage, were
seeded and maintained in 0.07 mM Ca11 KGM. When the cells attached, the
culture medium was changed to either 0.03 mM or 1.2 mM Ca11. In the
presence of 1.2 mM Ca11 the keratinocytes were induced to differentiate.
Cells were harvested when 80% confluent and 100% confluent, respectively.
Acute barrier disruption The skin of 6–8 wk old male hairless mice was
treated either by gently applying acetone-soaked cotton balls for 5–10 min or
by sequential applications of cellophane tape (Tesa Tuck, New Rochelle, NY)
as described previously (Menon et al, 1985; Proksch et al, 1990). Controls for
acetone perturbation of the barrier were treated with cotton balls soaked in
0.9% (wt/vol) sodium chloride. Untreated animals served as controls for tape
stripping. The TEWL was measured immediately after treatment using a Meeco
electrolytic water analyzer, as described previously (Menon et al, 1985). Animals
with a TEWL rate greater than 6 mg per cm2 per h (normal , 0.3 mg per
cm2 per h) after barrier disruption were included in this study. In some
experiments mice were covered immediately after barrier disruption by a finger
from a latex glove to occlude the disrupted area as described previously
(Grubauer et al, 1989).
Isolation of the epidermis Four hours following barrier disruption, the
animals were killed by Isoflurane anaethesia (Abbot Laboratories, Chicago, IL)
and the skin was excised. The subcutaneous fat was removed by scraping with
a scalpel blade. To separate whole epidermis, skin was placed in 10 mM
ethylenediamine tetraacetic acid in calcium and magnesium free PBS pH 7.4
for 35 min at 37°C (Jackson et al, 1992). The skin was blotted dry and the
epidermis was removed by scraping with a scalpel blade.
Fatty Acyl-CoA synthetase activity assay FACS activity was measured by
a radio-isotopic assay in keratinocytes by the method of Tanaka et al (1979).
Keratinocytes were homogenized in a buffer (0.25 M sucrose, 1 mM dithio-
threitol, 1 mM ethylenediamine tetraacetic acid) and the homogenates were
centrifuged at 800 3 g for 5 min. The resultant supernatants were used for
measuring enzyme activity. As reported by others (Tanaka et al, 1979), our
initial experiments also showed that the rate of reaction is linear up to 10 min
and plateaued by 15 min. Hence, in all subsequent assays the reaction time was
kept at 5 min. The assay mixture contained 0.1 M Tris-HCl buffer pH 8.0,
5 mM dithiothreitol, 0.15 M KCl, 15 mM MgCl2, 1.6 mM triton X-100,
10 mM ATP, 1 mM coenzyme A, and 1 mM [U-14C] palmitic acid in a final
reaction volume of 0.2 ml. The assay was initiated by addition of 5–10 µl of
enzyme suspension (5 µg protein) and the reaction was carried out at 37°C for
5 min. The reaction was terminated by adding 2.5 ml of a mixture containing
isopropanol:heptane:sulfuric acid 1 M (40:10:1 vol/vol/vol). The unreacted
palmitic acid was extracted with heptane and the radioactivity in the aqueous
phase containing palmitoyl-CoA was measured. Control reactions containing
no protein were run in parallel to correct for the background. FACS activity
is expressed as nmoles palmitoyl-CoA formed per mg protein per min. Protein
was assayed by the method of Bradford (Bio-Rad laboratories).
Extraction of Poly (A)1 RNA from keratinocytes Poly (A)1 RNA was
isolated using a variation of the proteinase-K extraction method. Briefly, cells
from two 100 mm dishes were washed with phosphate-buffered saline and
scraped into 5 ml solution A (0.5 M NaCl, 10 mM Tris pH 7.5, 1 mM
ethylenediamine tetraacetic acid, 1% sodium dodecyl sulfate, and 200 mg
proteinase-K per ml). The viscosity of the solution was reduced by passing
through a 25-gauge needle, and then incubating for 1 h at 37°C. Oligo(dT)-
cellulose, 7.5 mg, was added to each sample and incubated for 1 h. The
oligo(dT)-cellulose was washed and the poly (A)1 RNA eluted.
Isolation of epidermal mRNA and northern blotting Total RNA was
prepared by a variation of the guanidinium thiocyanate method, as described
previously (Jackson et al, 1992; Wood et al, 1992). Total RNA was purified
and added to oligo(dT)-cellulose to obtain poly (A)1 RNA. Northern blots
were prepared as described previously. The uniformity of sample applications
was checked by ultraviolet visualization of the acridine orange-stained gel before
transfer to Nytran membranes. In order to avoid any potential problems with
RNA transfer from the gels, the exposure to acridine orange was kept to a
minimum by staining the gels for only 1 min followed by 1 h of destaining.
The blots were exposed to X-ray films for various durations to ensure that
measurements were done on the linear portion of the curve, and the bands
were quantitated by densitometry (Bio-Rad Laboratories, Hercules, CA).
Quantitation of film, exposed in the linear range of sensitivity, was achieved
using a Biorad laboratories (Hercules, CA) densitometer. The densitometry
quantitation was adjusted for cyclophilin levels on the same blot and expressed
as fold of control, with the control as one.
Statistics Statistical significance was determined using a two-tailed unpaired
Student’s t test. Results are expressed as mean 6 SEM.
RESULTS
Several putative fatty acid transport related proteins are
expressed in human keratinocytes and regulated by
differentiation As shown in Fig 1(A), FATP, FABP-pm, and FACS
mRNA were detectable in human keratinocytes. The sizes of the
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Figure 1. Effect of differentiation on fatty acid transport related proteins.
Human keratinocytes were grown in low calcium or high calcium media as
described in Materials and Methods. (A) Northern blots were probed for FABP-
pm, FATP, FACS, and FAT mRNA. The left-hand three lanes for each probe
are 0.03 mM calcium and the right-hand three lanes are 1.2 mM calcium. Fat
mRNA was not detected under either culture condition. (B) Data are presented
as mean 6 SEM and expressed as fold over control corrected for loading using
cyclophillin levels (n 5 3).
Figure 2. Presence of fatty acid transport related proteins in murine
epidermis. Northern blots were prepared from murine epidermis and probed
for FATP-FABP-pm, FACS, and FAT mRNA. Each lane represents poly A1
RNA from two animals.
mRNA transcripts for FATP, FABP-pm, and FACS in keratinocytes
were identical to those previously reported in other tissues (Abumrad
et al, 1993; Schaffer and Lodish, 1994; Zhou et al, 1995; Berk et al,
1997). In contrast, FAT mRNA was not observed by northern blotting
in human keratinocytes.
The effect of differentiation was compared by growing human
keratinocyte cultures in either 0.03 or 1.2 mM calcium. In high
calcium, FAT mRNA was again not detected in human keratinocytes.
Differentiation did not effect FATP mRNA levels and resulted in an
µ50% decrease in FABP-pm mRNA levels (Fig 1B). In contrast,
FACS mRNA levels increased by 70% under high calcium conditions
(Fig 1B). Additionally, FACS activity was increased 45% in differenti-
ated keratinocytes (low calcium 108.3 6 7.0 versus high calcium
157.0 6 11.8 nmoles per mg per min, p , 0.01, n 5 6).
All putative fatty acid transport related proteins are expressed
in murine epidermis but only FAT increases after barrier
disruption FATP, FABP-pm, FACS, and FAT mRNA were all
present in murine epidermis (Fig 2). The transcript sizes of these
mRNA were identical to those previously reported in other tissues
and in keratinocytes.
To determine whether the expression of the mRNA for these
proteins in the epidermis is regulated by conditions that increase
Figure 3. Acetone disruption of the barrier increases FAT mRNA levels.
Mice were treated topically with acetone until a TEWL value of 6 mg per cm2
per h was achieved. Controls were treated similarly with saline. Poly A1 RNA
was isolated 4 h after barrier disruption and northern blotting was performed
as described in Materials and Methods. Data are presented as mean 6 SEM and
expressed as fold over control corrected for loading using cyclophilin levels.
n 5 5 for both groups.
epidermal fatty acid requirements, we next measured the mRNA levels
in the epidermis following barrier disruption. We have previously
shown that barrier disruption increases de novo fatty acid synthesis and
that inhibition of this increase in synthesis delays barrier recovery
(Grubauer et al, 1987; Man et al, 1993; Ottey et al, 1995). Barrier
disruption by acetone treatment did not significantly affect FATP,
FABP-pm, or FACS mRNA levels (Fig 3); however, FAT mRNA
levels increased µ2-fold (Fig 3). FAT has both 2.9 and 4.8 kb transcripts
and both transcripts of FAT increase following barrier disruption.
To determine if the increase in FAT mRNA was due to barrier
disruption or a nonspecific effect of acetone, we next disrupted the
barrier by an entirely different method, tape stripping. As found with
acetone treatment, tape stripping did not alter FATP, FABP-pm, or
FACS mRNA levels (data not shown). As observed following acetone
treatment, however, tape stripping increased both the 2.9 and the
4.8 kb mRNA transcripts for FAT (Fig 4).
To further link the increase in FAT mRNA levels with barrier
disruption we next artificially provided a permeability barrier by
immediately occluding the disrupted skin with an impermeable mem-
brane. As shown in Fig 4, occlusion completely blocked the increase
in both the 2.9 and the 4.8 kb FAT mRNA transcripts that occur
following tape stripping. These data indicate that the increase in FAT
mRNA that occurs after barrier disruption is not a nonspecific effect
secondary to injury, but rather is related to barrier disruption per se.
DISCUSSION
In this study, we demonstrate that two of the three putative fatty acid
transporters, FABP-pm and FATP, are expressed in human keratinocytes
in culture. In contrast, FAT expression was not found in cultured
human keratinocytes. In these studies we utilized a rat cDNA probe
to FAT; however, using this cDNA probe FAT was detected in HepG2
cells, a human hepatocyte line (data not shown), and therefore the
lack of expression in human keratinocytes is not due to a problem
with the rodent cDNA probe recognizing human FAT mRNA. FABP-
pm is unlikely to be responsible for the bulk of transport activity,
because previous studies have shown that antibodies directed against
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Figure 4. FAT mRNA levels increase following barrier disruption by
tape stripping and this increase is prevented by occlusion. Mice were
tape stripped 3–5 times successively until a TEWL value of 6 mg per cm2 per
h was achieved. Some of the animals were immediately occluded with a Latex
wrap. Poly A1 RNA was isolated 4 h after barrier disruption and northern
blotting was performed as described in Materials and Methods. Data are presented
as mean 6 SEM and expressed as fold of control corrected for loading
using cyclophilin levels. n 5 5 for all groups, *p , 0.05 compared with
control, †p , 0.05 compared with tape stripped.
FABP-pm did not inhibit fatty acid uptake in human keratinocytes,
but did inhibit uptake in HepG2 cells (Schurer et al, 1994). FATP
might be a good candidate to facilitate fatty acid uptake into keratino-
cytes, because this transporter exhibits a higher affinity for arachadonic
acid than oleic acid (Schaffer and Lodish, 1994), which matches the
increased uptake of arachidonic acid compared with oleic acid seen in
keratinocytes (Schurer et al, 1994).
With calcium induced differentiation FATP expression does not
change and FABP-pm expression decreases by 50%. In contrast, FACS
mRNA levels increase by 70%. Moreover, FACS activity increases by
45% in keratinocytes induced to differentiate by calcium treatment.
FACS catalyzes the activation of long chain fatty acids to acyl-CoA
esters that are then utilized in anabolic or catabolic pathways. Moreover,
studies have indicated that FACS is a catalyst for fatty acid uptake into
cells (Schaffer and Lodish, 1994), perhaps because the formation of
acyl-CoA fatty acids prevents the efflux of fatty acid, thereby assuring
a unidirectional transport process. Thus, the increase in FACS activity
and mRNA levels in differentiated keratinocytes could enhance fatty
acid uptake and utilization and is consistent with the high requirements
of differentiated keratinocytes to concentrate fatty acids in lamellar
bodies, the precursor of the extracellular lamellar membranes of the
stratum corneum.
Not only were mRNA for FATP, FABP-pm, and FACS present in
intact murine epidermis, but FAT mRNA was also found. Moreover,
disruption of the barrier resulted in a 2-fold increase in FAT mRNA
levels without altering FATP, FABP-pm, or FACS mRNA levels. The
increase in FAT mRNA was seen after barrier disruption by both
acetone and tape stripping, and was prevented by occlusion with a
water impermeable membrane, indicating that this increase was not a
nonspecific injury response but rather was related to perturbed barrier
function. As will be discussed below, FAT has important functions in
addition to fatty acid transport, and therefore it is uncertain whether
the purpose of this increase in FAT expression is to enhance fatty acid
transport. Furthermore, previous studies by our laboratory demonstrated
only minimal changes in epidermal fatty acid uptake after barrier
disruption, consistent with the absence of changes in FABP-pm, FATP,
and FACS expression (Grubauer et al, 1987).
Murine FAT is a homolog of human CD36, based on the high level
of homology of both the DNA and the amino acid sequences (Abumrad
et al, 1993). CD36 has many potential functions in addition to fatty
acid transport, including being a receptor for collagen, thrombospondin,
oxidized lipoproteins, and anionic phospholipids, mediating cell adhe-
sion, involvement in signal transduction via tyrosine kinases, and
phagocytosis of apoptotic cells (Greenwalt et al, 1992; Asch, 1996).
Which of these many functions of CD36 are of physiologic importance
is unresolved and humans deficient in CD36 do not have any obvious
abnormalities (Greenwalt et al, 1992; Asch, 1996). CD36 has been
demonstrated in sweat glands using immunohistochemistry (Begany
et al, 1994). Variable staining for CD36 has been reported in normal
epidermis, with some investigators reporting no CD36 (Barker et al,
1989) and others reporting the presence of small amounts in basal and/
or suprabasal cells (Willis et al, 1991). In inflammatory diseases such as
psoriasis, atopic dermatitis, irritant dermatitis, or lichan planus, or
following wounding, prominent CD36 staining occurs in the stratum
granulosum layer (Juhlin, 1989; Willis et al, 1991; Barker et al, 1989;
Begany et al, 1994; Simon et al, 1996). The level of CD36 has been
related to the hyperproliferative state of the epidermis (Willis et al,
1991) but the mechanism for this association is unknown. Following
barrier disruption epidermal DNA synthesis increases and this increase
is inhibited by occlusion (Proksch et al, 1991) and therefore it is
possible that the increase in FAT mRNA observed in our study is also
related to the proliferative state of the epidermis.
Which of these fatty acid transport related proteins play an important
role in fatty acid uptake in intact epidermis is unclear. Until recombinant
DNA technology produces mice with null mutations in each of these
proteins, it will be impossible to determine if they have important
roles in keratinocyte fatty acid uptake in vivo. Additionally, in this
study we primarily measured mRNA levels and it is possible that
mRNA levels do not perfectly reflect changes in protein/activity.
Humans deficient in CD36 do not develop obvious cutaneous abnorm-
alities, suggesting that FAT (CD36) is not the sole transporter responsible
for essential fatty acid uptake (Greenwalt et al, 1992; Asch, 1996).
All three of the putative fatty acid transporters measured in this
study are located in the plasma membrane and all have been shown to
facilitate the active uptake of external fatty acids into cells. These
transporters, including FABP-pm, are distinct from fatty acid binding
proteins (FABP), which are low molecular cytosolic proteins that bind
hydrophobic ligands with high affinity and are thought to regulate the
levels of free fatty acids in the cell and facilitate their trafficking within
the cell (reviewed in Bass, 1985; Kaikaus et al, 1990). FABP are
members of a multigene family of over 20 intracellular proteins that
are expressed in liver, intestine, cardiac muscle, adipose, and peripheral
nerve myelin and do not have a defined role in fatty acid transport
into cells. FABP have also been identified in normal, psoriatic, and
neoplastic epidermis. Epidermal fatty acid binding protein (E-FABP)
is a 15 kDa protein (pl 5.6) with a high affinity for oleic acid
but demonstrates no binding of retinoids, cholesterol, or squalene
(Siegenthaler et al, 1993, 1994). E-FABP is present at very low levels
in normal human skin, but is elevated in psoriatic lesions. E-FABP
protein levels are also increased in cultured keratinocytes by calcium
induced differentiation. A similar FABP cloned from keratinocytes,
called psoriasis-associated fatty acid-binding protein (PA-FABP), has a
calculated molecular weight of 15,164 Da, a pl of 6.96, and has up to
56% amino acid homology with other FABP (Madsen et al, 1992).
The levels of PA-FABP increase in psoriasis and with differentiation
of keratinocytes in culture; however, no binding data were given
for PA-FABP. A third keratinocyte lipid-binding protein (MAL-1),
identified in mouse skin tumors, has been cloned (Krieg et al, 1993;
Kane et al, 1996). MAL-1 is 15 kDa, has extensive amino acid
homology with other FABP, and can be immunoprecipitated by anti-
rat liver FABP anti-serum. MAL-1 has a high affinity for oleic acid
and arachidonic acid; this affinity declines with shorter chain length
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fatty acids and there is very little binding of retinoids. MAL-1 is
expressed at high levels in neoplastic tissue and at lower levels in
epidermis. Two calcium binding proteins, MRP8 (S100A8) and
MRP14 (S100A9), form a 34 kDa complex (FA-p34) that binds
unsaturated fatty acids, such as oleic, linoleic, and arachidonic acid
with high affinity, while having low affinity for palmitic and stearic
acid (Siegenthaler et al, 1997). Lowering free calcium results in the
loss of fatty acid binding to FA-p34. Additionally, FA-p34 is present
in calcium induced-differentiating keratinocytes and psoriatic ker-
atinocytes (Siegenthaler et al, 1997). Lastly, Schurer et al have proposed
that FABP in the epidermis exist as heterodimers (Schurer et al, 1993).
They demonstrated that high affinity fatty acid binding was attributable
to a high molecular weight fraction (90–100 kDa) that disassociated
under denaturing conditions, and on western blots a 32 kDa protein
reacted with rabbit anti-rat heart FABP antibody (Schurer et al, 1993).
Although FABP have important roles in the intracellular movement
of fatty acids, they have not been definitively shown to mediate fatty
acid entry into cells. In contrast, FATS, FATP, FABP-pm, and FACS
have all been demonstrated in certain cell types to facilitate the entry
of fatty acids into cells.
In summary, this study demonstrates that several putative fatty acid
transport related proteins and fatty acyl CoA synthase are expressed in
keratinocytes and epidermis and that the expression of these proteins
may be regulated by differentiation and barrier disruption.
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